FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W6244724> ?p ?o ?g. }

• W6244724 endingPage "147" @default.
• W6244724 startingPage "127" @default.
• W6244724 abstract "It has been more than 10 years since the discovery that the expansion of a simple CAG trinucleotide repeat within the coding region of the androgen receptor gene leads to the motor neuronopathy spinal and bulbar muscular atrophy (SBMA). A flurry of investigation into this and the other, more recently discovered, polyglutamine diseases has led to an understanding of many aspects of the molecular pathogenesis of this family of diseases. A characteristics pathological feature of the polyglutamine diseases is the occurrence in affected neurons of ubiquitinated aggregates; such aggregates also contain, among others, proteins involved in the folding and degradation of the mutant proteins. Aggregates themselves are likely not directly cytotoxic, but rather mark the accumulation of all or part of the mutant protein. Furthermore, aggregation occurs because of the inefficient clearance of the mutant protein by the ubiquitin-proteasome pathway for protein degradation. These findings are common to the polyglutamine diseases and reflect the general problem of folding/degrading expanded polyglutamines. In SBMA, the altered metabolism of the androgen receptor is ligand dependent. How the accumulation of the mutant protein causes neuronal dysfunction and disease is not well understood, but several cellular processes have been implicated. Although these findings provide insight into the toxic function of the expanded polyglutamine protein, additional investigations have led to the finding that intrinsic AR transactivational function is somewhat diminished in the presence of the expanded polyglutamine; this likely leads to the partial androgen insensitivity that characterizes patients with SBMA. The recent development of useful animal and cell models of SBMA will lead to increased understanding of disease pathogenesis, as well as to the development of new and better therapeutic strategies." @default.
• W6244724 created "2016-06-24" @default.
• W6244724 creator A5054050922 @default.
• W6244724 creator A5061482430 @default.
• W6244724 date "2002-01-01" @default.
• W6244724 modified "2023-10-09" @default.
• W6244724 title "Trinucleotide repeat disease" @default.
• W6244724 cites W1484266129 @default.
• W6244724 cites W1484666375 @default.
• W6244724 cites W1494506707 @default.
• W6244724 cites W1499287136 @default.
• W6244724 cites W1507515137 @default.
• W6244724 cites W1508200717 @default.
• W6244724 cites W1604791477 @default.
• W6244724 cites W1643390591 @default.
• W6244724 cites W1855026199 @default.
• W6244724 cites W1962249623 @default.
• W6244724 cites W1962420039 @default.
• W6244724 cites W1966489527 @default.
• W6244724 cites W1970491283 @default.
• W6244724 cites W1971955021 @default.
• W6244724 cites W1974477415 @default.
• W6244724 cites W1979213838 @default.
• W6244724 cites W1982999121 @default.
• W6244724 cites W1985474993 @default.
• W6244724 cites W1988110501 @default.
• W6244724 cites W1988679331 @default.
• W6244724 cites W1996920204 @default.
• W6244724 cites W1997315176 @default.
• W6244724 cites W1997369314 @default.
• W6244724 cites W1998476721 @default.
• W6244724 cites W1998982625 @default.
• W6244724 cites W2000731870 @default.
• W6244724 cites W2002673255 @default.
• W6244724 cites W2002791165 @default.
• W6244724 cites W2004428615 @default.
• W6244724 cites W2005506430 @default.
• W6244724 cites W2006101507 @default.
• W6244724 cites W2006268333 @default.
• W6244724 cites W2007589116 @default.
• W6244724 cites W2013029120 @default.
• W6244724 cites W2016756042 @default.
• W6244724 cites W2017111453 @default.
• W6244724 cites W2017762713 @default.
• W6244724 cites W2020206460 @default.
• W6244724 cites W2021549542 @default.
• W6244724 cites W2022854533 @default.
• W6244724 cites W2025277453 @default.
• W6244724 cites W2033529039 @default.
• W6244724 cites W2034493211 @default.
• W6244724 cites W2036054914 @default.
• W6244724 cites W2038610378 @default.
• W6244724 cites W2041170006 @default.
• W6244724 cites W2042437056 @default.
• W6244724 cites W2042716629 @default.
• W6244724 cites W2052300085 @default.
• W6244724 cites W2056303044 @default.
• W6244724 cites W2056545208 @default.
• W6244724 cites W2058543711 @default.
• W6244724 cites W2062554378 @default.
• W6244724 cites W2062682951 @default.
• W6244724 cites W2066663076 @default.
• W6244724 cites W2069833726 @default.
• W6244724 cites W2070757426 @default.
• W6244724 cites W2078178939 @default.
• W6244724 cites W2079196098 @default.
• W6244724 cites W2082610063 @default.
• W6244724 cites W2085609235 @default.
• W6244724 cites W2092890658 @default.
• W6244724 cites W2099685145 @default.
• W6244724 cites W2101065984 @default.
• W6244724 cites W2101411281 @default.
• W6244724 cites W2102203964 @default.
• W6244724 cites W2106786078 @default.
• W6244724 cites W2107792324 @default.
• W6244724 cites W2108102646 @default.
• W6244724 cites W2108421300 @default.
• W6244724 cites W2113333419 @default.
• W6244724 cites W2113998330 @default.
• W6244724 cites W2117138295 @default.
• W6244724 cites W2117862287 @default.
• W6244724 cites W2119619688 @default.
• W6244724 cites W2120040531 @default.
• W6244724 cites W2120325083 @default.
• W6244724 cites W2123231783 @default.
• W6244724 cites W2128840922 @default.
• W6244724 cites W2130538948 @default.
• W6244724 cites W2133194590 @default.
• W6244724 cites W2135486647 @default.
• W6244724 cites W2135890131 @default.
• W6244724 cites W2135897093 @default.
• W6244724 cites W2136364567 @default.
• W6244724 cites W2142710492 @default.
• W6244724 cites W2143359863 @default.
• W6244724 cites W2148688106 @default.
• W6244724 cites W2154528582 @default.
• W6244724 cites W2154660110 @default.
• W6244724 cites W2157187767 @default.

• next